Benjamin Shepherd is a recognized exchange-traded fund (ETF), mutual fund and stock expert with an extensive background analyzing time-tested funds, including their managers and strategies. Ben looks for investments that have proven themselves in both bull and bear markets. Ben also specializes in covering emerging markets, pinpointing the most dynamic investments in developing nations for market-beating growth.
Ben is chief investment strategist of Global Investment Strategist, which examines top-performing investments in Brazil, Russia, India, China, Japan, Indonesia, South Korea, and other rising economic powers. He’s also chief investment strategist of Inflation Survival Letter, born from his years learning from famed investment guru Louis Rukeyser and subsequently serving as editor of Louis Rukeyser’s Wall Street and Louis Rukeyser’s Mutual Funds. In July 2013 Ben launched the Inflation Survival Letter, which guides investors on positioning themselves now for inflation’s inevitable arrival.
Along with these duties, Ben finds time to regularly contribute to Personal Finance, Investing Daily’s flagship product.
Did you miss the first Coca-Cola? The first McDonalds? Apple’s IPO? Here’s your second chance. From Eastern Europe to the Pacific Rim to South America – new markets are buoying investor profits. These are multiple market opportunities – new industrial giants, pharmaceuticals, and high-tech. Plus moneyed new consumers with any eye to buy every gadget – from phones to refrigerators – that have long been staples in our own society. For investors, it’s a once-in-a-lifetime ground-floor opportunity to profit from the birth of new economies. Learn More
Don’t let your wealth erode – lock in investments that will thrive as inflation spirals up! Learn More
Pundits are overreacting to China’s latest GDP data.
Makers of store brand products are booming.
Monetary stimulus hasn’t just worked in America, as the euro zone’s recovery suggests.
The search for a better diabetes treatment could pay off big one day for the company that emerges to the fore.
The rising cost of food isn’t an isolated U.S. problem, a trend that will spark greater global inflation.
Despite its persistent security problems, Israel has become a compelling source of investment opportunity.
Here’s a great play on the booming demand for long-term care.
Economic reform could be in the cards for Brazil, a happy prospect for investors.
Despite political posturing on Capitol Hill, this drug company’s promising new drug won’t fall under any price controls, making the stock a good bet now.
The Fed is turning its focus away from the job market and toward inflation.